Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04185558 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs
A NA study of Diabetic Foot and Chronic Ulcer, sponsored by RedDress.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
- 16
- Study locations
NCT04185558 is a NA study of Diabetic Foot and Chronic Ulcer that has completed, run by RedDress. The registered enrollment target is 119 participants, below the 10,337-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The trial reports 16 study locations across 8 states.
The verdict
NCT04185558, a NA study of Diabetic Foot and Chronic Ulcer, has completed, sponsored by RedDress.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
- 16
- Study locations
Study Summary
* The study is a multi-center, prospective, randomized, controlled, single blinded clinical study consisting of 150 subjects from up to 20 centers. * The subjects are randomized to receive 1 of 2 treatments, either with ActiGraft and standard of care (SOC) or with SOC alone. * The target ulcers are evaluated weekly by the investigator. The subject is treated once a week, to receive weekly applications of the ActiGraft + SOC or SOC until for up to 12 weeks or until the study ulcer has completely healed (i.e., 100% closure as assessed by the Investigator and blinded assessor and confirmed 2 weeks later at the healing confirmation visit (HCV). One additional visit per week is optional for both arms, for the purpose of changing only (1) the secondary dressing in the ActiGraft arm or (2) change the standard of care dressing in the control arm. * Immediately after the study ulcer is confirmed as completely healed, subjects will enter the 12-week Follow-up Phase. During the Follow-Up phase, subjects will be evaluated twice during the first month and then monthly for two additional visits every 4 weeks until the completion of the 12-week Follow-up Phase.
Conditions Studied
Interventions
- DEVICE ActiGraft
- DEVICE Standard of Care
Study Locations (16)
California
- New Hope Podiatry Group Inc - Los Angeles
- Greater Los Angeles VA - Los Angeles
- Center for Clinical Research Inc - San Francisco
- Olive View UCLA Education & Research Institute - Sylmar
Other
- Wound Care South Africa - Germiston
- Haute Care - Lyttelton
- Eloquent Health & Wellness - Tyger Valley
- Acinadem Altunizade - Istanbul
Florida
- Eric J Lullove DPM PA - Coconut Creek
- Future Health Research Clinic - Miami
- Barry University Clinical Research - North Miami Beach
Alabama
- Institute for Advanced Wound Care - Montgomery
Hawaii
- Pacific Vascular Institute - Hilo
Massachusetts
- Boston Medical Center - Boston
Nevada
- Wahab Consulting and Research LLC - Las Vegas
Pennsylvania
- Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2019-12-20 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04185558
The ClinicalTrials.gov registry entry for NCT04185558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,337-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The listed sponsor is RedDress, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 2 interventions - of which ActiGraft is the first listed.
NCT04185558 reports 16 study locations spanning 8 distinct geographic areas - top geographies include California, Other, Florida.
Frequently Asked Questions
What is clinical trial NCT04185558 about?
NCT04185558 is a clinical study titled "Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs". * The study is a multi-center, prospective, randomized, controlled, single blinded clinical study consisting of 150 subjects from up to 20 centers. * The subjects are randomized to receive 1 of 2 treatments, either with ActiGraft and standard of care (SOC) or with SOC alone. * The target ulcers are ...
What is the current status of trial NCT04185558?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2019-12-20. Estimated completion is 2024-04-01.
What conditions does trial NCT04185558 study?
This clinical trial studies the following conditions: Diabetic Foot, Chronic Ulcer.
What interventions are being tested in trial NCT04185558?
The interventions under investigation include: ActiGraft (DEVICE), Standard of Care (DEVICE).
Who is sponsoring clinical trial NCT04185558?
This trial is sponsored by RedDress, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04185558 being conducted?
This trial has 16 study locations across Alabama, California, Florida, Hawaii, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
RECRUITING · NA
-
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.